TY - JOUR
T1 - Apolipoprotein M Attenuates Anthracycline Cardiotoxicity and Lysosomal Injury
AU - Guo, Zhen
AU - Valenzuela Ripoll, Carla
AU - Picataggi, Antonino
AU - Rawnsley, David
AU - Ozcan, Mualla
AU - Chirinos, Julio A.
AU - Chendamarai, Ezhilarasi
AU - Girardi, Amanda
AU - Riehl, Terrence
AU - Evie, Hosannah
AU - Diab, Ahmed
AU - Kovacs, Attila
AU - Hyrc, Krzysztof
AU - Ma, Xiucui
AU - Asnani, Aarti
AU - Shewale, Swapnil V.
AU - Scherrer-Crosbie, Marielle
AU - Cowart, Lauren Ashley
AU - Parks, John S.
AU - Zhao, Lei
AU - Gordon, David
AU - Ramirez-Valle, Francisco
AU - Margulies, Kenneth B.
AU - Cappola, Thomas P.
AU - Desai, Ankit A.
AU - Pedersen, Lauren N.
AU - Bergom, Carmen
AU - Stitziel, Nathan
AU - Rettig, Michael
AU - Dipersio, John
AU - Hajny, Stefan
AU - Christoffersen, Christina
AU - Diwan, Abhinav
AU - Javaheri, Ali
N1 - Publisher Copyright:
© 2023 The Authors
PY - 2023/3
Y1 - 2023/3
N2 - Apolipoprotein M (ApoM) binds sphingosine-1-phosphate (S1P) and is inversely associated with mortality in human heart failure (HF). Here, we show that anthracyclines such as doxorubicin (Dox) reduce circulating ApoM in mice and humans, that ApoM is inversely associated with mortality in patients with anthracycline-induced heart failure, and ApoM heterozygosity in mice increases Dox-induced mortality. In the setting of Dox stress, our studies suggest ApoM can help sustain myocardial autophagic flux in a post-transcriptional manner, attenuate Dox cardiotoxicity, and prevent lysosomal injury.
AB - Apolipoprotein M (ApoM) binds sphingosine-1-phosphate (S1P) and is inversely associated with mortality in human heart failure (HF). Here, we show that anthracyclines such as doxorubicin (Dox) reduce circulating ApoM in mice and humans, that ApoM is inversely associated with mortality in patients with anthracycline-induced heart failure, and ApoM heterozygosity in mice increases Dox-induced mortality. In the setting of Dox stress, our studies suggest ApoM can help sustain myocardial autophagic flux in a post-transcriptional manner, attenuate Dox cardiotoxicity, and prevent lysosomal injury.
KW - TFEB
KW - anthracycline
KW - apolipoprotein M
KW - autophagy
KW - cardiomyopathy
UR - http://www.scopus.com/inward/record.url?scp=85150029297&partnerID=8YFLogxK
U2 - 10.1016/j.jacbts.2022.09.010
DO - 10.1016/j.jacbts.2022.09.010
M3 - Article
C2 - 37034289
AN - SCOPUS:85150029297
SN - 2452-302X
VL - 8
SP - 340
EP - 355
JO - JACC: Basic to Translational Science
JF - JACC: Basic to Translational Science
IS - 3
ER -